Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
SINOCHEM PHARMACEUTICAL Participated in CPhI Worldwide Europe
2019-11-08 17:36
Omega-3 Fatty-acid Enriched Parenteral Nutrition Improves Patient Outcomes
2019-11-08 11:00
Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost
2019-11-07 21:02
TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million
2019-11-07 19:04
Bactiguard Holding AB (publ): Interim Report for Q3 2019
2019-11-07 15:23
ASH 2019 | CStone's anti-PD-L1 antibody demonstrates a complete response rate of 31.8% in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma
2019-11-07 11:02
Bioeq Announces Coherus as Marketing and Distribution Partner for Its Biosimilar to Lucentis® (ranibizumab) in the U.S.
2019-11-07 05:14
Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364
2019-11-07 01:40
Henlius HLX01 (Rituximab Injection) Wins "Biosimilar Initiative of the Year" at Global Generics & Biosimilars Awards 2019
2019-11-07 01:00
EpiVax Announces Publication of Antigen-Specific Tolerance Induction by Tregitope in Nature Scientific Reports
2019-11-06 18:01
Nanoform Wins the CPhI Excellence in Pharma Award for Formulation
2019-11-06 17:21
15 Years of P-MEC China Driving Global Pharma Technology Forward in China
2019-11-06 14:00
Inovio Demonstrates 80% 6-Month Progression-Free Survival In Phase 2 Glioblastoma Multiforme (GBM) Study with INO-5401 In Combination with PD-1 Inhibitor Libtayo® (cemiplimab)
2019-11-05 21:00
Health Charities Benefit from Nationwide Fundraising Campaign
2019-11-05 05:30
Boehringer Ingelheim and Lilly modernise alliance to focus full expertise on Jardiance®
2019-11-04 22:00
Healthcare Support Remains Strong For Singaporeans With Advanced Breast Cancer, But Patients Call For Greater Disease Education, Survey Finds
2019-11-04 08:15
Encore Medical Education Will Publish the Official Best of SABCS(R) News From the 2019 San Antonio Breast Cancer Symposium (SABCS(R)) Starting December 12, 2019
2019-11-01 23:00
High Performance Swine Production With Reduced Use of Antibiotics: Second Workshop by EW Nutrition and OPP Group
2019-11-01 20:22
Dachser Air & Sea Logistics certified for pharmaceutical shipments on three continents
2019-11-01 09:00
Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA
2019-10-31 23:00
1
186
187
188
189
190
247